Shyamal Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
- Revenue Growth %
- Profit Growth -313.75%
- Ebitda -173.44%
- Net Worth -1849.88%
- Total Assets 8695.73%
About Shyamal Life Science
Shyamal Life Science Private Limited (SLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 January 2021 (Four years and one month 3 days old ). Its registered office is in Valsad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.00 Cr.
Chetan Shah, Dipak Shah, Bharatkumar Shah, and One other member serve as directors at the Company.
Company Details
- Location
Valsad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24299GJ2021PTC119597
- Company No.
119597
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2021
- Date of AGM
20 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Shyamal Life Science?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chetan Shah  | Director | 19-Jan-2021 | Current |
| Dipak Shah | Director | 19-Jan-2021 | Current |
| Bharatkumar Shah | Director | 19-Jan-2021 | Current |
| Prakash Tamboli | Director | 19-Jan-2021 | Current |
Financial Performance of Shyamal Life Science.
Shyamal Life Science Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 313.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1849.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shyamal Life Science?
Unlock access to Shyamal Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Asian Azoles Private LimitedChetan Shah and Dipak Shah are mutual person
Charges (Loans)
₹20.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Nov 2022 | Hdfc Bank Limited | ₹2.00 Cr | Open |
How Many Employees Work at Shyamal Life Science?
Shyamal Life Science has a workforce of 0 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shyamal Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shyamal Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.